A 0·5 kb fragment of Streptomyces venezuelae ISP5230 genomic DNA was amplified by PCR using primers based on consensus sequences of cysteine synthase isozyme A from bacteria. The deduced amino acid sequence of the PCR product resembled not only cysteine synthase sequences from prokaryotes and eukaryotes but also eukaryotic cystathionine β-synthase sequences. Probing an Str. venezuelae genomic library with the PCR product located a hybridizing colony from which pJV207 was isolated. Sequencing and analysis of the Str. venezuelae DNA insert in pJV207 detected two ORFs. The deduced amino acid sequence of ORF1 matched both cysteine synthase and cystathionine β-synthase sequences in GenBank, but its size favoured assignment as a cystathionine β-synthase. ORF2 in the pJV207 insert was unrelated in function to ORF1; in its sequence the deduced product resembled acetyl-CoA transferases, but disruption of the ORF did not cause a detectable phenotypic change. Disruption of ORF1 failed to elicit cysteine auxotrophy in wild-type Str. venezuelae, but in the cys-28 auxotroph VS263 it prevented restoration of prototrophy with homocysteine or methionine supplements. The change in phenotype implicated loss of the transsulfuration activity that in the wild-type converts these supplements to cysteine. This study concludes that disruption of ORF1 inactivates a cbs gene, the product of which participates in cysteine synthesis by transsulfuration. Enzyme assays of Str. venezuelae mycelial extracts confirmed the formation of cysteine by thiolation of O-acetylserine, providing the first unambiguous detection of this activity in a streptomycete. Enzyme assays also detected cystathionine γ-synthase, cystathionine β-lyase and cystathionine γ-lyase activity in the extracts and showed that the substrate for cystathionine γ-synthase was O-succinyl-homoserine. Based on assay results, the cys-28 mutation in Str. venezuelae VS263 does not inactivate the cysteine synthase gene but impairs expression in cultures grown in minimal medium.
Steroids with hydroxylation at C14 are drawing increased attention because of their diverse biological activities and applications. P-450lun from Cochliobolus lunatus is the first fungal cytochrome P450 reported to have 14α-hydroxylase activity. Studies have shown that P-450lun catalyzes the hydroxylation of progesterone (PROG) at C14α with low regiospecificity and activity. To improve its regiospecificity and activity for PROG, truncated forms of P-450lun and its cognate redox partner CPRlun were functionally co-expressed in Escherichia coli. Then, a semi-rational protein engineering approach was applied to P-450lun, resulting in a double-site mutant E109A/F297W with enhanced 14α-position selectivity for PROG compared with the wild-type P-450lun (97% vs. 28%). Protein structure analysis revealed that the F297W substitution can hinder the binding pose for 11β-hydroxylation product formation. Finally, whole-cell catalysis was optimized, and the final titer of 14α-OH-PROG reached 16.0 mg/L. This is the first report where a fungal 14α-hydroxylase was functionally expressed in Escherichia coli. The steroid hydroxylation system obtained in this study can serve as a basis for the synthesis of 14α-hydroxylated PROG and the rapid evolution of eukaryotic cytochrome P-450lun.
The aerobic catabolism of steroids in bacteria is highly conserved, and the mechanism of steroid degradation in mycobacteria has been extensively studied. However, the branching modification pathways of steroids in mycobacteria remain a mystery, including the likely roles of cytochromes P450. In this study, we unraveled the CYP105S17 converting androst-4-ene-3,17-dione (AD) to 17β-hydroxy-4-androstene-3,16-dione (16-oxo-TS), which was subsequently reduced to 16α,17β-dihydroxy-androst-4-ene-3-one (16α-OH-TS) under reductive conditions in Mycolicibacterium neoaurum. By applying this modification pathway, the genetically modified strains overexpressing CYP105S17 were able to produce 16α-OH-TS at titers 13.0 g/L with a conversion rate of 91.9% (supplemented with 20 g/L phytosterols as the substrate) through a two-stage biotransformation process. This is the first instance of utilizing the native P450 of Mycobacterium to produce 16-hydroxylated steroid intermediates at the 10 g scale. This work provides invaluable perspectives and guidance to researchers seeking to understand the complexities of steroid metabolism in bacteria, and also highlights the great potential of Mycobacterium as a production platform for hydroxylated steroid intermediates or pharmaceuticals.
About Me
Biotransformation and Metabolic Engineering Scientist
Biotransformation and Metabolic Engineering Scientist